Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 6101-6150 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05916365
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
PHASE3
Active, not recruiting
200 participants
Started: May 23, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
32 locations
NCT05886634
A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
PHASE2
Active, not recruiting
16 participants
Started: May 23, 2023 · Completed: May 23, 2027
7 conditions
1 sponsor
7 locations
NCT05860595
Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.
NA
Active, not recruiting
3 participants
Started: May 23, 2023 · Completed: Oct 24, 2025
1 condition
2 sponsors
1 location
NCT06150521
Hysteroscopic Myomectomy for Submucosal Myomas Without Energy Instruments
N/A
Active, not recruiting
200 participants
Started: May 23, 2023 · Completed: May 23, 2026
1 condition
1 sponsor
1 location
NCT05870488
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
PHASE4
Active, not recruiting
110 participants
Started: May 23, 2023 · Completed: Nov 30, 2027
4 conditions
1 sponsor
14 locations
NCT06565975
Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France
N/A
Active, not recruiting
112 participants
Started: May 23, 2023 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT06476860
Proteinuria During Sepsis and Septic Shock: Characterization and Association With ARDS
N/A
Active, not recruiting
100 participants
Started: May 23, 2023 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05784545
Dietary Supplementation With Blueberry in OA
NA
Active, not recruiting
58 participants
Started: May 22, 2023 · Completed: Sep 1, 2027
1 condition
3 sponsors
1 location
NCT05997095
Post-operative Electrical Muscle Stimulation to Stimulate Muscle Protein Synthesis in Humans
NA
Active, not recruiting
10 participants
Started: May 22, 2023 · Completed: Dec 28, 2025
1 condition
1 sponsor
1 location
NCT05747794
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy
PHASE2/PHASE3
Active, not recruiting
849 participants
Started: May 22, 2023 · Completed: Jul 31, 2027
1 condition
1 sponsor
22 locations
NCT05293626
Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations
PHASE1/PHASE2
Active, not recruiting
12 participants
Started: May 22, 2023 · Completed: Dec 31, 2029
1 condition
1 sponsor
3 locations
NCT07122466
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
N/A
Active, not recruiting
24 participants
Started: May 22, 2023 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05916378
Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies
N/A
Active, not recruiting
150 participants
Started: May 22, 2023 · Completed: Mar 30, 2025
1 condition
2 sponsors
1 location
NCT05972954
OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
PHASE2
Active, not recruiting
32 participants
Started: May 22, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
9 locations
NCT05825716
Ifaa Effectiveness Evaluation on Food Security and Nutrition
N/A
Active, not recruiting
3,317 participants
Started: May 21, 2023 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT06344780
Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer
N/A
Active, not recruiting
200 participants
Started: May 20, 2023 · Completed: Feb 1, 2025
1 condition
1 sponsor
1 location
NCT05873725
Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin
N/A
Active, not recruiting
150 participants
Started: May 20, 2023 · Completed: May 31, 2024
2 conditions
1 sponsor
1 location
NCT05445219
Identifying Therapeutic Hemodialysis Targets Through Cerebrovascular Reactivity; RESPIRACT 2
N/A
Active, not recruiting
37 participants
Started: May 20, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05857540
The Effects of Upper-Extremity Plyometric Combined Strength Training in Overhead Athletes With Shoulder Instability
NA
Active, not recruiting
64 participants
Started: May 20, 2023 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
NCT05849493
Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder
NA
Active, not recruiting
400 participants
Started: May 19, 2023 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06473064
Evaluation of Feasibility and Aesthetic Outcomes of Benelli Technique for Nipple Sparing Mastectomy in Surgical Treatment of Grade 3 and 4 Gynecomastia
NA
Active, not recruiting
30 participants
Started: May 19, 2023 · Completed: Oct 19, 2025
1 condition
1 sponsor
1 location
NCT05596409
ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study
PHASE2
Active, not recruiting
61 participants
Started: May 19, 2023 · Completed: Jul 31, 2027
1 condition
1 sponsor
34 locations
NCT07006246
Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa
PHASE4
Active, not recruiting
1,900 participants
Started: May 19, 2023 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05894343
Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease
PHASE1/PHASE2
Active, not recruiting
13 participants
Started: May 19, 2023 · Completed: Oct 31, 2029
1 condition
1 sponsor
6 locations
NCT05406700
Niraparib In Recurrent IDH 1/2 Gliomas
EARLY_PHASE1
Active, not recruiting
16 participants
Started: May 18, 2023 · Completed: Feb 28, 2026
5 conditions
2 sponsors
1 location
NCT05663866
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
PHASE2
Active, not recruiting
68 participants
Started: May 18, 2023 · Completed: Jul 30, 2026
1 condition
1 sponsor
36 locations
NCT06003582
Co-production and Feasibility RCT of Intervention to Improve the Mental Health of Children With a Social Worker
NA
Active, not recruiting
30 participants
Started: May 18, 2023 · Completed: Feb 28, 2025
3 conditions
6 sponsors
1 location
NCT05641207
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System
NA
Active, not recruiting
40 participants
Started: May 18, 2023 · Completed: Nov 30, 2025
2 conditions
1 sponsor
7 locations
NCT05870943
Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study
NA
Active, not recruiting
48 participants
Started: May 18, 2023 · Completed: May 31, 2025
1 condition
3 sponsors
1 location
NCT05908734
A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer
PHASE1/PHASE2
Active, not recruiting
71 participants
Started: May 18, 2023 · Completed: Mar 31, 2027
1 condition
1 sponsor
44 locations
NCT05732220
Mobile EMA-based Peer Counselling for Youth Smokers
NA
Active, not recruiting
105 participants
Started: May 18, 2023 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT05404308
Interest of a Weekly Consultation by a Medical Electro Radiology Manipulator (MERM) in Addition to the Follow-up by the Radiotherapist to Improve the Collection of Radio-induced Toxicities in Patients Undergoing Proton Therapy
NA
Active, not recruiting
92 participants
Started: May 17, 2023 · Completed: Jul 31, 2026
4 conditions
1 sponsor
1 location
NCT05855135
Assessment of Combined CCM and ICD Device in HFrEF
NA
Active, not recruiting
300 participants
Started: May 17, 2023 · Completed: Jul 31, 2027
10 conditions
1 sponsor
59 locations
NCT05433454
Impact of Outreach on Medicaid Enrollment
NA
Active, not recruiting
224,000 participants
Started: May 17, 2023 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT05456295
Comparative Effect of Carbon Fiber Orthosis Cuff Design on Preference, Comfort, and Mechanics
NA
Active, not recruiting
35 participants
Started: May 17, 2023 · Completed: Sep 30, 2026
3 conditions
2 sponsors
1 location
NCT06750523
Advancing Early Bone Health: New Frontiers for Osteoporosis Prevention
NA
Active, not recruiting
200 participants
Started: May 17, 2023 · Completed: Nov 30, 2025
3 conditions
3 sponsors
2 locations
NCT06065800
STEELEX® Sternum Set + BONE WAX® + STEELEX® Electrode Set in Patients Undergoing Cardiac Surgery
N/A
Active, not recruiting
150 participants
Started: May 17, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05767021
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE3
Active, not recruiting
172 participants
Started: May 17, 2023 · Completed: Sep 30, 2025
2 conditions
1 sponsor
120 locations
NCT05744414
Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries
N/A
Active, not recruiting
30 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05678010
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
PHASE1
Active, not recruiting
54 participants
Started: May 17, 2023 · Completed: May 17, 2028
6 conditions
2 sponsors
5 locations
NCT05670106
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC
PHASE2
Active, not recruiting
62 participants
Started: May 16, 2023 · Completed: Nov 14, 2025
1 condition
1 sponsor
18 locations
NCT05683691
Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer
NA
Active, not recruiting
400 participants
Started: May 16, 2023 · Completed: Apr 30, 2029
1 condition
1 sponsor
26 locations
NCT05856435
Tailoring CPP for the Foster Care Setting
NA
Active, not recruiting
16 participants
Started: May 16, 2023 · Completed: Aug 30, 2027
1 condition
3 sponsors
1 location
NCT04586049
Cardiovascular and Neurovascular Regulation in GWI
N/A
Active, not recruiting
70 participants
Started: May 16, 2023 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT05791201
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
PHASE1/PHASE2
Active, not recruiting
7 participants
Started: May 16, 2023 · Completed: May 29, 2026
1 condition
1 sponsor
16 locations
NCT05553834
PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung
PHASE2
Active, not recruiting
60 participants
Started: May 16, 2023 · Completed: Jan 1, 2027
1 condition
2 sponsors
2 locations
NCT05681884
Safety and Efficacy of Faricimab in Patients With NPDR
PHASE2
Active, not recruiting
179 participants
Started: May 16, 2023 · Completed: Apr 13, 2026
1 condition
2 sponsors
16 locations
NCT05676203
A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients
PHASE3
Active, not recruiting
250 participants
Started: May 16, 2023 · Completed: Jan 31, 2027
1 condition
2 sponsors
43 locations
NCT05877521
Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief
PHASE2
Active, not recruiting
76 participants
Started: May 16, 2023 · Completed: May 16, 2027
2 conditions
1 sponsor
1 location
NCT06218095
Pregnancy and Postpartum Period Venous Thromboembolism and Simulation
NA
Active, not recruiting
81 participants
Started: May 15, 2023 · Completed: Aug 10, 2024
2 conditions
1 sponsor
1 location
Previous
1
More pages
120
121
122
123
124
125
126
More pages
431
Next